Dapagliflozin reduces risk for hyperkalemia in HFrEF patients treated with MRAs: Study Dr. Shravani Dali20 Aug 2021 9:00 AM ISTDapagliflozin Reduces Hyperkalemia Risk in Heart Failure and reduced ejection fraction (HFrEF) in patients treated with mineralocorticoid receptor...
REALITY trial supports restrictive blood transfusion strategy in anaemic MI patients Dr. Kamal Kant Kohli2 Sept 2020 4:41 AM ISTRestricted blood transfusion use was as good as liberal use in anaemic heart attack patients clarifies REALITY trial.
Pacemaker implantation may be effective therapy of fainting for selected people Dr. Kamal Kant Kohli1 Sept 2020 11:38 PM ISTResearchers have reported that Implanting a pacemaker can be an effective treatment for selected people with unpredictable fainting episodes. The...
Icosapent Ethyl helps achieve coronary plaque regression in CAD: EVAPORATE trial Medha Baranwal1 Sept 2020 6:41 PM ISTUSA: Treatment of coronary atherosclerosis patients with icosapent ethyl (IPE) helped to achieve significant regression of low attenuation...
BP drugs lower heart attack, stroke risk in people with Normal BP also: ESC update Dr. Kamal Kant Kohli31 Aug 2020 9:00 PM ISTBlood pressure-lowering medications can help prevent heart attacks and strokes – even in people with normal blood pressure, based on new research from...
Men with high BP have lesser Penile Flow- ESC update Hina Zahid30 Aug 2020 6:45 PM ISTSophia Antipolis, France - Men with untreated high blood pressure have poorer penile blood flow than those with normal blood pressure, according to...
Guidelines to treat non-ST-segment elevation ACS released at ESC Congress 2020 Hina Zahid30 Aug 2020 6:45 PM ISTSophia Antipolis, France: One in five patients die within a year after the most common type of heart attack. European Society of Cardiology (ESC)...
